CTRI/2017/11/010656已完成2 期
Study of primary hypertension and therapeutic evaluation of sharbat aftimoon in its management.
ational Institute of Unani Medicine0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients with stage- 1 primary hypertension
- •ranging systolic pressure140 to 159 mmHg and
- •diastolic pressure 90 to 99 mmHg.
- •2.Patients who will agree to sign the informed
- •consent form and follow up the protocol.
- •3.Age group: 30 to 65 years.
- •4.Gender:Either
排除标准
- •1.Patients with cardiac arrhythmias (chronic atrial
- •fibrillation, frequent premature ventricular and
- •atrial contractions, ventricular or
- •supraven¬tricular tachycardia, tachycardia [heart
- •rate > 100 beats per minute]), atrioventricular
- •2.Patients with malignant hypertension.
- •3.Patients with the episodes of marked arterial
- •hypotension (systolic BP < 90 mmHg)
- •4.Patients with the history of myocardial
- •infarction or acute cerebrovascular events,
- •stable angina or vasospastic angina, valvular
- •5.Patients with the positive history of angioedema.
- •6.Patients with the history of chronic liver
- •disease, acute or chronic renal failure, Bronchial
- •asthma and Diabetes mellitus.
- •7.Lactating mothers and pregnant women.
研究者
相似试验
已完成
3 期
Treatment of HypertensionCardiovascular DiseasesHeart DiseasesVascular DiseasesHypertensionNCT00000484National Heart, Lung, and Blood Institute (NHLBI)
已完成
Unknown
The effects of combined therapy for hypertension on arterial functiohypertension, type 2 diabetes mellitusJPRN-jRCT1091220034Masumi Ai, MD, PhDBioethics Research Center, Tokyo Medical and Dental University60
进行中（未招募）
不适用
The evaluation of patients with acute hypertension and intracerebral hemorrhage with intravenous clevidipine treatment - ACCELERATEAcute hypertension in patients who present with intracerebral hemorrhageMedDRA version: 9.1Level: LLTClassification code 10022754Term: Intracerebral hemorrhageMedDRA version: 9.1Level: LLTClassification code 10020772Term: HypertensionEUCTR2008-000230-53-DEThe Medicines Company60
已完成
不适用
Treatment of Hypertension in Primary Care in SpainHypertensionNCT00868881AstraZeneca2,160
已完成
不适用
Retrospective Survey for Patients With Hypertension and Diabetes MellitusHypertensionNCT00681278AstraZeneca2,000